Ferric Citrate Controls Phosphorus, Cuts ESA Use
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
Kidney Week 2014 Anemia
ESA Use May Lower Risk of Transfusion
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Earlier Use of ESAs Benefits Non-Dialysis Kidney Disease (CKD) Patients
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.
Giving Vitamin B6 Ups Resistance to ESAs
New finding on vitamin B6 is the opposite of what investigators hypothesized on patients with anemia.
Data Challenge IV Iron Withholding Guideline
IV iron in anemia hemodialysis patients hospitalized for bacterial infections found not to worsen outcomes.
Anemia Management Practices Shift, Study Finds
Use of erythropoiesis-stimulating agents in anemia patients decreased, while use of iron increased.
Higher Serum Ferritin Ups Mortality in Hemodialysis Patients
Hemodialysis (HD) patients in highest quartile of serum ferritin had an increased risk of all-cause, cardiovascular, and infection-related mortality.
Prolonged Bleeding Times Linked to Severe Anemia in Chronic Kidney Disease (CKD)
Hemoglobin level below 8 mg/dL associated with 82% increased odds of prolonged bleeding time with anemia.
Anemia Found to Affect Renal Recovery from Acute Kidney Injury (AKI)
Highest quintile of hemoglobin associated with 6-fold increased odds of complete or partial recovery of anemia in acute kidney injury (AKI).
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Week 2014 Anemia
Loading... 
Loading...